Ambac Q1 revenue up 27% to $63M but net loss widens; adjusted EBITDA negative

OCTAVE SPECIALTY GROUP INC

2025-Q1 EPS reported -$1.22 revenue$62,756,000

Total P&C premium production up 70% to $318M; revenue from continuing ops $63M (+27% YoY).
Net loss from continuing ops attributable to shareholders of $16.1M vs $4.1M loss in Q1'24.
Diluted EPS from continuing ops loss of $1.22 vs prior year EPS of $0.44 gain.
Adjusted EBITDA to shareholders negative $1.3M vs positive $0.4M; Cirrata segment adjusted EBITDA up 136%.
Legacy business sale pending only Wisconsin regulatory approval; discontinued ops net loss of $30.2M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.